Live from the NIH registry
Studies recruiting near Fargo right now
Top 25 of 211 recruiting studies, sorted by proximity — each links to its official registry page
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
Knee Injuries, Pain, Postoperative
Phase 4
Interventional 148 participants sought
Sanford Health — Fargo, North Dakota (2.0 mi)
· Sponsor: Sanford Health
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Sanford Fargo Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Eli Lilly and Company
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
Psoriasis
Phase 1
Interventional 90 participants sought
Axis Clincals USA/ Red River Research Patners. LLC — Fargo, North Dakota (2.0 mi)
· Sponsor: SFA Therapeutics
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma, Liposarcoma
Phase 3
Interventional 250 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Advanced Cancer, Metastatic Cancer
N/A
Interventional 1,000 participants sought
Sanford Health — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance Foundation Trials, LLC.
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Huntington's Disease
N/A
Observational 35,000 participants sought
Sanford Health — Fargo, North Dakota (2.0 mi)
· Sponsor: CHDI Foundation, Inc.
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Sanford Health - Fargo — Fargo, North Dakota (2.0 mi)
· Sponsor: Novo Nordisk A/S
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Red River Research Partners - Fargo- Site Number : 8400037 — Fargo, North Dakota (2.0 mi)
· Sponsor: Sanofi
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
Sanford South University Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Elute, Inc.
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Midwest Birth Outcomes and Indigenous American Pregnancy
Pregnancy
N/A
Observational 80 participants sought
Sanford Health — Fargo, North Dakota (2.0 mi)
· Sponsor: Sanford Health
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Malignant Neoplasm
Phase 2
Interventional 140 participants sought
Sanford Health Roger Maris Cancer Center ( Site 0039) — Fargo, North Dakota (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Obesity, Overweight
Phase 3
Interventional 300 participants sought
Lillestol Research LLC — Fargo, North Dakota (2.0 mi)
· Sponsor: Novo Nordisk A/S
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Sanford Broadway Medical Centre — Fargo, North Dakota (2.0 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Cancer
N/A
Observational 500 participants sought
Sanford Roger Maris Cancer Center (Fargo) — Fargo, North Dakota (2.0 mi)
· Sponsor: Tempus AI
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Sanford Roger Maris Cancer Center — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology